6 analysts have expressed a variety of opinions on Stoke Therapeutics (NASDAQ:STOK) over the past quarter, offering a diverse set of opinions from bullish to bearish.
Summarizing their recent assessments, the table below illustrates the evolving sentiments in the past 30 days and compares them to the preceding months.
| Bullish | Somewhat Bullish | Indifferent | Somewhat Bearish | Bearish | |
|---|---|---|---|---|---|
| Total Ratings | 4 | 1 | 1 | 0 | 0 |
| Last 30D | 0 | 0 | 0 | 0 | 0 |
| 1M Ago | 3 | 1 | 1 | 0 | 0 |
| 2M Ago | 1 | 0 | 0 | 0 | 0 |
| 3M Ago | 0 | 0 | 0 | 0 | 0 |
In the assessment of 12-month price targets, analysts unveil insights for Stoke Therapeutics, presenting an average target of $20.33, a high estimate of $35.00, and a low estimate of $13.00. This upward trend is apparent, with the current average reflecting a 59.45% increase from the previous average price target of $12.75.
Deciphering Analyst Ratings: An In-Depth...
Login or create a forever free account to read this news
Sign up/Log in